Ukraine authorizes clinical trials of two COVID-19 vaccines

Ukraine authorizes clinical trials of two COVID-19 vaccines

The Ministry of Health has authorized clinical trials of two COVID-19 vaccines in Ukraine.

According to Ukrinform, a respective order signed by the minister of health has been published on the ministry's website.

"To allow a clinical trial of a medicinal product intended for measures to prevent the occurrence and spread, localization and elimination of coronavirus disease (COVID-19)," the order reads.

Sanofi Aventis Ukraine LLC submitted an application for the study.

According to the document, a "multi-stage, modified double-blind phase 3 study will be conducted in many parallel groups to evaluate the efficacy, safety and immunogenicity of two adjuvant recombinant protein vaccines (monovalent and bivalent) against SARS-CoV-2 to prevent COVID-19 in adults aged 18 years and older."

The study will be conducted in four medical institutions in Kyiv and one medical institution in Vinnytsia.


While citing and using any materials on the Internet, links to the website not lower than the first paragraph are mandatory. In addition, citing the translated materials of foreign media outlets is possible only if there is a link to the website and to the website of a foreign media outlet. Citing and using materials in offline media, mobile apps, Smart TV are allowed only with written permission from Ukrinform. News and publications marked as "Advertisement" and "PR" and articles in the section "Releases" include promoted content, and an advertiser is responsible for the content.

© 2015-2024 Ukrinform. All rights reserved.

Website design Studio Laconica

Extended searchHide extended search
By period: